Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium hyaluronate 0.15%
- Development stage
- Unknown
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
Sodium hyaluronate 0.15% is an ophthalmic solution primarily used as an artificial tear for treating dry eye conditions and promoting corneal healing. It is a viscoelastic polymer that helps stabilize the tear film, lubricate the ocular surface, and maintain hydration. It has been investigated for its efficacy in various ocular conditions, including dry eyes associated with diabetic retinopathy, ocular surface disease following cataract surgery, and corneal epithelial healing after corneal cross-linking for keratoconus. It is also used as part of topical treatments for conditions like ocular mucous membrane pemphigoid.
- Brand names
- Eye Still
- Other names
- Sodium hyaluronate 0.15%HA 0.15%Hyaluni
02
Targets
CD44 (CD44 antigen)
Beyond the preview
Go deeper on sodium hyaluronate 0.15%.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium hyaluronate 0.15%.